In line with the authors’ connotation, we observed significantly reduced DARS2 expression in MASLD patients with increased FGF21 expression (Figure S5), and with few exceptions, patients with increased FGF21 expression showed marked up‐regulation of genes coding for the mitochondrial respiration change (Figure 4F). This evidence concerns the gene DARS2 and metabolic dysfunction-associated steatotic liver disease.